Inhalation Toxicity of Propineb. Part I: Results of Subacute Inhalation Exposure Studies in Rats

This article addresses results from repeated 1- and 4-wk inhalation exposure studies in Wistar rats with solid aerosol (dust) atmospheres of propineb, a zinc bisdithiocarbamate homopolymer that is used as an agrochemical fungicide. Groups of 10 rats/sex were exposed nose-only to mean concentrations...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Inhalation toxicology 2003-04, Vol.15 (5), p.411-434
Hauptverfasser: Pauluhn, Jürgen, Rosenbruch, Martin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 434
container_issue 5
container_start_page 411
container_title Inhalation toxicology
container_volume 15
creator Pauluhn, Jürgen
Rosenbruch, Martin
description This article addresses results from repeated 1- and 4-wk inhalation exposure studies in Wistar rats with solid aerosol (dust) atmospheres of propineb, a zinc bisdithiocarbamate homopolymer that is used as an agrochemical fungicide. Groups of 10 rats/sex were exposed nose-only to mean concentrations of 3.97, 11.24, and 21.95 mg propineb/m 3 using an exposure regimen of 6 h/day, 5 days/wk for 4 wk. Concentrations were selected based on results from a pilot study in which rats were exposed under identical conditions on 5 consecutive days for 6 h/day to mean concentrations of 10.1, 19.9, 38.1, and 78.7 mg/m 3. Both studies demonstrated that with respect to muscular effects female rats were remarkably more susceptible as compared to males. Female rats exposed to 11.24 mg/m 3 and above displayed characteristic signs of toxicity that included weakness and flaccid paralysis of hindlegs and ensuing immobilization that was considered to be the cause of emaciation and ensuing mortality in some rats. There was an apparent reciprocal relationship of concentration and the manifestation of clinical evidence of muscular dysfunction; that is, the onset in female rats exposed to 11.24, 21.95, 38.1, and 78.7 mg/m 3 was on days 15, 8, 4, and 3, respectively. In contrast, none of the male rats elaborated comparable effects up to 38.1 mg/m 3. Neuromuscular measures included leg grip strength and supplemented the clinical findings, whereas the landing foot splay was only minimally affected. Hematology and clinical pathology endpoints, including those addressing thyroidal function, were unobtrusive up to and including 78.7 mg/m 3. Lung weights were significantly increased in groups exposed to 21.95 mg/m 3 and above, especially in male rats. The microscopic examinations made in the 4-wk study demonstrated an increased incidence of intraalveolar material and enlarged, foamy alveolar macrophages at 3.97 mg/m 3 and above. Especially in female rats an atrophy of thigh muscle fibers, including increased nuclei and focal degeneration, occurred at 11.24 mg/m 3 and above. TTCA (2-thiazolidinethione-4-carboxylic acid) in urine, a metabolite and biomarker of exposure to CS 2, which is a putative breakdown product of propineb, was overproportially higher in the female rats exposed to 11.24 mg/m 3 and above. This biomarker appears to accumulate with time. This finding provides indirect evidence that the etiopathologic cause of neuromuscular changes is related to intermediary levels of CS 2. T
doi_str_mv 10.1080/08958370304465
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_12682856</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19259402</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-928c8f9ad1fadde7679c2a6ce4fc3492e3131c6a2c47d9dde3bd0623f8734eeb3</originalsourceid><addsrcrecordid>eNp1kEtvEzEUhS0EomlhyxJ5xW6CHxOPzQ5VhUaqRNWWtbnjuVZcTcbBD9H8eyZKJOiiq7s43zm6-gj5wNmSM80-M21WWnZMsrZVq1dkwZnhTacMf00Wh7CZU31GznN-ZIwpJru35IwLpYVeqQX5tZ42MEIJcaIP8Sm4UPY0enqb4i5M2C_pLaRC11_oHeY6lnwI72sPrhak_5WvnnYx14T0vtQhYKZhondQ8jvyxsOY8f3pXpCf364eLq-bmx_f15dfbxrXCl4aI7TT3sDAPQwDdqozToBy2HonWyNQcsmdAuHabjAzIfuBKSG97mSL2MsL8um4u0vxd8Vc7DZkh-MIE8aaLTdiZVomZnB5BF2KOSf0dpfCFtLecmYPTu1zp3Ph42m59lsc_uEniTNgjkCYfExb-BPTONgC-zEmn2ByIVv54rh-1t0gjGXjIKF9jDVNs7KX_voLzeSWUQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19259402</pqid></control><display><type>article</type><title>Inhalation Toxicity of Propineb. Part I: Results of Subacute Inhalation Exposure Studies in Rats</title><source>MEDLINE</source><source>Taylor &amp; Francis Medical Library - CRKN</source><source>Taylor &amp; Francis Journals Complete</source><creator>Pauluhn, Jürgen ; Rosenbruch, Martin</creator><creatorcontrib>Pauluhn, Jürgen ; Rosenbruch, Martin</creatorcontrib><description>This article addresses results from repeated 1- and 4-wk inhalation exposure studies in Wistar rats with solid aerosol (dust) atmospheres of propineb, a zinc bisdithiocarbamate homopolymer that is used as an agrochemical fungicide. Groups of 10 rats/sex were exposed nose-only to mean concentrations of 3.97, 11.24, and 21.95 mg propineb/m 3 using an exposure regimen of 6 h/day, 5 days/wk for 4 wk. Concentrations were selected based on results from a pilot study in which rats were exposed under identical conditions on 5 consecutive days for 6 h/day to mean concentrations of 10.1, 19.9, 38.1, and 78.7 mg/m 3. Both studies demonstrated that with respect to muscular effects female rats were remarkably more susceptible as compared to males. Female rats exposed to 11.24 mg/m 3 and above displayed characteristic signs of toxicity that included weakness and flaccid paralysis of hindlegs and ensuing immobilization that was considered to be the cause of emaciation and ensuing mortality in some rats. There was an apparent reciprocal relationship of concentration and the manifestation of clinical evidence of muscular dysfunction; that is, the onset in female rats exposed to 11.24, 21.95, 38.1, and 78.7 mg/m 3 was on days 15, 8, 4, and 3, respectively. In contrast, none of the male rats elaborated comparable effects up to 38.1 mg/m 3. Neuromuscular measures included leg grip strength and supplemented the clinical findings, whereas the landing foot splay was only minimally affected. Hematology and clinical pathology endpoints, including those addressing thyroidal function, were unobtrusive up to and including 78.7 mg/m 3. Lung weights were significantly increased in groups exposed to 21.95 mg/m 3 and above, especially in male rats. The microscopic examinations made in the 4-wk study demonstrated an increased incidence of intraalveolar material and enlarged, foamy alveolar macrophages at 3.97 mg/m 3 and above. Especially in female rats an atrophy of thigh muscle fibers, including increased nuclei and focal degeneration, occurred at 11.24 mg/m 3 and above. TTCA (2-thiazolidinethione-4-carboxylic acid) in urine, a metabolite and biomarker of exposure to CS 2, which is a putative breakdown product of propineb, was overproportially higher in the female rats exposed to 11.24 mg/m 3 and above. This biomarker appears to accumulate with time. This finding provides indirect evidence that the etiopathologic cause of neuromuscular changes is related to intermediary levels of CS 2. The data of this investigation suggest that the toxicity of inhaled propineb is characterized by two independent effects, namely, responses occurring at the alveolar level and muscular weakness, especially in female rats. With respect to the latter finding, the no-observed-adverse-effect level (NOAEL) of the 4-wk study is 3.97 mg/m 3. Further study is needed to clarify whether the pulmonary response observed at this exposure level is consistent with an adaptive or an early adverse effect.</description><identifier>ISSN: 0895-8378</identifier><identifier>EISSN: 1091-7691</identifier><identifier>DOI: 10.1080/08958370304465</identifier><identifier>PMID: 12682856</identifier><language>eng</language><publisher>England: Informa UK Ltd</publisher><subject>Administration, Inhalation ; Animals ; Dose-Response Relationship, Drug ; Female ; Lung - drug effects ; Lung - pathology ; Male ; Muscle, Skeletal - drug effects ; Muscle, Skeletal - pathology ; propineb ; Rats ; Rats, Wistar ; Zineb - administration &amp; dosage ; Zineb - analogs &amp; derivatives ; Zineb - toxicity</subject><ispartof>Inhalation toxicology, 2003-04, Vol.15 (5), p.411-434</ispartof><rights>2003 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-928c8f9ad1fadde7679c2a6ce4fc3492e3131c6a2c47d9dde3bd0623f8734eeb3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.1080/08958370304465$$EPDF$$P50$$Ginformahealthcare$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.1080/08958370304465$$EHTML$$P50$$Ginformahealthcare$$H</linktohtml><link.rule.ids>314,780,784,27923,27924,59646,59752,60435,60541,61220,61255,61401,61436</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12682856$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pauluhn, Jürgen</creatorcontrib><creatorcontrib>Rosenbruch, Martin</creatorcontrib><title>Inhalation Toxicity of Propineb. Part I: Results of Subacute Inhalation Exposure Studies in Rats</title><title>Inhalation toxicology</title><addtitle>Inhal Toxicol</addtitle><description>This article addresses results from repeated 1- and 4-wk inhalation exposure studies in Wistar rats with solid aerosol (dust) atmospheres of propineb, a zinc bisdithiocarbamate homopolymer that is used as an agrochemical fungicide. Groups of 10 rats/sex were exposed nose-only to mean concentrations of 3.97, 11.24, and 21.95 mg propineb/m 3 using an exposure regimen of 6 h/day, 5 days/wk for 4 wk. Concentrations were selected based on results from a pilot study in which rats were exposed under identical conditions on 5 consecutive days for 6 h/day to mean concentrations of 10.1, 19.9, 38.1, and 78.7 mg/m 3. Both studies demonstrated that with respect to muscular effects female rats were remarkably more susceptible as compared to males. Female rats exposed to 11.24 mg/m 3 and above displayed characteristic signs of toxicity that included weakness and flaccid paralysis of hindlegs and ensuing immobilization that was considered to be the cause of emaciation and ensuing mortality in some rats. There was an apparent reciprocal relationship of concentration and the manifestation of clinical evidence of muscular dysfunction; that is, the onset in female rats exposed to 11.24, 21.95, 38.1, and 78.7 mg/m 3 was on days 15, 8, 4, and 3, respectively. In contrast, none of the male rats elaborated comparable effects up to 38.1 mg/m 3. Neuromuscular measures included leg grip strength and supplemented the clinical findings, whereas the landing foot splay was only minimally affected. Hematology and clinical pathology endpoints, including those addressing thyroidal function, were unobtrusive up to and including 78.7 mg/m 3. Lung weights were significantly increased in groups exposed to 21.95 mg/m 3 and above, especially in male rats. The microscopic examinations made in the 4-wk study demonstrated an increased incidence of intraalveolar material and enlarged, foamy alveolar macrophages at 3.97 mg/m 3 and above. Especially in female rats an atrophy of thigh muscle fibers, including increased nuclei and focal degeneration, occurred at 11.24 mg/m 3 and above. TTCA (2-thiazolidinethione-4-carboxylic acid) in urine, a metabolite and biomarker of exposure to CS 2, which is a putative breakdown product of propineb, was overproportially higher in the female rats exposed to 11.24 mg/m 3 and above. This biomarker appears to accumulate with time. This finding provides indirect evidence that the etiopathologic cause of neuromuscular changes is related to intermediary levels of CS 2. The data of this investigation suggest that the toxicity of inhaled propineb is characterized by two independent effects, namely, responses occurring at the alveolar level and muscular weakness, especially in female rats. With respect to the latter finding, the no-observed-adverse-effect level (NOAEL) of the 4-wk study is 3.97 mg/m 3. Further study is needed to clarify whether the pulmonary response observed at this exposure level is consistent with an adaptive or an early adverse effect.</description><subject>Administration, Inhalation</subject><subject>Animals</subject><subject>Dose-Response Relationship, Drug</subject><subject>Female</subject><subject>Lung - drug effects</subject><subject>Lung - pathology</subject><subject>Male</subject><subject>Muscle, Skeletal - drug effects</subject><subject>Muscle, Skeletal - pathology</subject><subject>propineb</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Zineb - administration &amp; dosage</subject><subject>Zineb - analogs &amp; derivatives</subject><subject>Zineb - toxicity</subject><issn>0895-8378</issn><issn>1091-7691</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEtvEzEUhS0EomlhyxJ5xW6CHxOPzQ5VhUaqRNWWtbnjuVZcTcbBD9H8eyZKJOiiq7s43zm6-gj5wNmSM80-M21WWnZMsrZVq1dkwZnhTacMf00Wh7CZU31GznN-ZIwpJru35IwLpYVeqQX5tZ42MEIJcaIP8Sm4UPY0enqb4i5M2C_pLaRC11_oHeY6lnwI72sPrhak_5WvnnYx14T0vtQhYKZhondQ8jvyxsOY8f3pXpCf364eLq-bmx_f15dfbxrXCl4aI7TT3sDAPQwDdqozToBy2HonWyNQcsmdAuHabjAzIfuBKSG97mSL2MsL8um4u0vxd8Vc7DZkh-MIE8aaLTdiZVomZnB5BF2KOSf0dpfCFtLecmYPTu1zp3Ph42m59lsc_uEniTNgjkCYfExb-BPTONgC-zEmn2ByIVv54rh-1t0gjGXjIKF9jDVNs7KX_voLzeSWUQ</recordid><startdate>20030425</startdate><enddate>20030425</enddate><creator>Pauluhn, Jürgen</creator><creator>Rosenbruch, Martin</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20030425</creationdate><title>Inhalation Toxicity of Propineb. Part I: Results of Subacute Inhalation Exposure Studies in Rats</title><author>Pauluhn, Jürgen ; Rosenbruch, Martin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-928c8f9ad1fadde7679c2a6ce4fc3492e3131c6a2c47d9dde3bd0623f8734eeb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Administration, Inhalation</topic><topic>Animals</topic><topic>Dose-Response Relationship, Drug</topic><topic>Female</topic><topic>Lung - drug effects</topic><topic>Lung - pathology</topic><topic>Male</topic><topic>Muscle, Skeletal - drug effects</topic><topic>Muscle, Skeletal - pathology</topic><topic>propineb</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Zineb - administration &amp; dosage</topic><topic>Zineb - analogs &amp; derivatives</topic><topic>Zineb - toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pauluhn, Jürgen</creatorcontrib><creatorcontrib>Rosenbruch, Martin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Inhalation toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pauluhn, Jürgen</au><au>Rosenbruch, Martin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhalation Toxicity of Propineb. Part I: Results of Subacute Inhalation Exposure Studies in Rats</atitle><jtitle>Inhalation toxicology</jtitle><addtitle>Inhal Toxicol</addtitle><date>2003-04-25</date><risdate>2003</risdate><volume>15</volume><issue>5</issue><spage>411</spage><epage>434</epage><pages>411-434</pages><issn>0895-8378</issn><eissn>1091-7691</eissn><abstract>This article addresses results from repeated 1- and 4-wk inhalation exposure studies in Wistar rats with solid aerosol (dust) atmospheres of propineb, a zinc bisdithiocarbamate homopolymer that is used as an agrochemical fungicide. Groups of 10 rats/sex were exposed nose-only to mean concentrations of 3.97, 11.24, and 21.95 mg propineb/m 3 using an exposure regimen of 6 h/day, 5 days/wk for 4 wk. Concentrations were selected based on results from a pilot study in which rats were exposed under identical conditions on 5 consecutive days for 6 h/day to mean concentrations of 10.1, 19.9, 38.1, and 78.7 mg/m 3. Both studies demonstrated that with respect to muscular effects female rats were remarkably more susceptible as compared to males. Female rats exposed to 11.24 mg/m 3 and above displayed characteristic signs of toxicity that included weakness and flaccid paralysis of hindlegs and ensuing immobilization that was considered to be the cause of emaciation and ensuing mortality in some rats. There was an apparent reciprocal relationship of concentration and the manifestation of clinical evidence of muscular dysfunction; that is, the onset in female rats exposed to 11.24, 21.95, 38.1, and 78.7 mg/m 3 was on days 15, 8, 4, and 3, respectively. In contrast, none of the male rats elaborated comparable effects up to 38.1 mg/m 3. Neuromuscular measures included leg grip strength and supplemented the clinical findings, whereas the landing foot splay was only minimally affected. Hematology and clinical pathology endpoints, including those addressing thyroidal function, were unobtrusive up to and including 78.7 mg/m 3. Lung weights were significantly increased in groups exposed to 21.95 mg/m 3 and above, especially in male rats. The microscopic examinations made in the 4-wk study demonstrated an increased incidence of intraalveolar material and enlarged, foamy alveolar macrophages at 3.97 mg/m 3 and above. Especially in female rats an atrophy of thigh muscle fibers, including increased nuclei and focal degeneration, occurred at 11.24 mg/m 3 and above. TTCA (2-thiazolidinethione-4-carboxylic acid) in urine, a metabolite and biomarker of exposure to CS 2, which is a putative breakdown product of propineb, was overproportially higher in the female rats exposed to 11.24 mg/m 3 and above. This biomarker appears to accumulate with time. This finding provides indirect evidence that the etiopathologic cause of neuromuscular changes is related to intermediary levels of CS 2. The data of this investigation suggest that the toxicity of inhaled propineb is characterized by two independent effects, namely, responses occurring at the alveolar level and muscular weakness, especially in female rats. With respect to the latter finding, the no-observed-adverse-effect level (NOAEL) of the 4-wk study is 3.97 mg/m 3. Further study is needed to clarify whether the pulmonary response observed at this exposure level is consistent with an adaptive or an early adverse effect.</abstract><cop>England</cop><pub>Informa UK Ltd</pub><pmid>12682856</pmid><doi>10.1080/08958370304465</doi><tpages>24</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0895-8378
ispartof Inhalation toxicology, 2003-04, Vol.15 (5), p.411-434
issn 0895-8378
1091-7691
language eng
recordid cdi_pubmed_primary_12682856
source MEDLINE; Taylor & Francis Medical Library - CRKN; Taylor & Francis Journals Complete
subjects Administration, Inhalation
Animals
Dose-Response Relationship, Drug
Female
Lung - drug effects
Lung - pathology
Male
Muscle, Skeletal - drug effects
Muscle, Skeletal - pathology
propineb
Rats
Rats, Wistar
Zineb - administration & dosage
Zineb - analogs & derivatives
Zineb - toxicity
title Inhalation Toxicity of Propineb. Part I: Results of Subacute Inhalation Exposure Studies in Rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T03%3A03%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhalation%20Toxicity%20of%20Propineb.%20Part%20I:%20Results%20of%20Subacute%20Inhalation%20Exposure%20Studies%20in%20Rats&rft.jtitle=Inhalation%20toxicology&rft.au=Pauluhn,%20J%C3%BCrgen&rft.date=2003-04-25&rft.volume=15&rft.issue=5&rft.spage=411&rft.epage=434&rft.pages=411-434&rft.issn=0895-8378&rft.eissn=1091-7691&rft_id=info:doi/10.1080/08958370304465&rft_dat=%3Cproquest_pubme%3E19259402%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19259402&rft_id=info:pmid/12682856&rfr_iscdi=true